Key result
Cardioneuroablation is an emerging and promising therapy for treating vasovagal syncope, functional atrioventricular block, and sinus dysfunction by targeting ganglionated plexi.
Why the study?
Cardioneuroablation is an emerging therapy with several approaches due to complex autonomic nervous system modulation, prompting a description of current techniques.
This review summarizes the current techniques, targets, and endpoints for cardioneuroablation in the management of vasovagal syncope and functional bradyarrhythmias.
Should not yet change practice for vasovagal syncope; leaves open cardioneuroablation's role pending randomized trials.
Cardioneuroablation is an emerging therapy to treat vasovagal syncope, functional atrioventricular block and sinus dysfunction. Currently, there are several effective approaches due to the complex modulation of autonomic nervous system. In this review, we describe techniques of this innovative therapy based on published literature and our experiences.
No takes yet. Share an insight, caveat, or question.
A 2019 study conducted a review in Vasovagal Syncope, Sinus Node Dysfunction, and Functional Atrioventricular Block. Cardioneuroablation was evaluated. Cardioneuroablation is an emerging and promising therapy for treating vasovagal syncope, functional atrioventricular block, and sinus dysfunction by targeting ganglionated plexi.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: